| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 39.01M | — |
| Operating expense | — | — |
| Net income | -44.74M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PACB returned -2.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -27.8% |
| 1 year | -2.2% |
| 5 years | -95.7% |
| 10 years | -83.8% |
| All-time high | $34.97 (Jun 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PACB would be worth today ›No. Pacific Biosciences of California, Inc. has not paid a dividend in the past 12 months.
Pacific Biosciences of California, Inc. stock trades on NASDAQ under the ticker symbol PACB.
Pacific Biosciences of California, Inc. is part of the Healthcare sector.
Pacific Biosciences of California, Inc. has a market cap of 419.62M USD, based on the latest quote.
Pacific Biosciences of California, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
